On episode #47 of the podcast “This Week in Virology”, Vincent and Dick discuss influenza virus-like particle vaccines produced in insect and plant cells, rapid sharing of influenza research, and answer listener questions about cytomegalovirus, viral evolution and symbiosis and much more.
Plant derived virus particles are definitely practical. There are a number of plant viruses that are excellent for that purpose. Tobacco is a nice plant to use because of TMV (tobacco mosaic virus), but there are others. There are good methods for purification such as Watanabe 1952 or Gooding 1967 http://www.ncbi.nlm.nih.gov/pubmed/6075009
Try talking to Bryce Falk at UCD. He's very knowledgable about TMV and other viruses for protein expression. bwfalk@ucdavis.edu
BrianHanley
Plant derived virus particles are definitely practical. There are a number of plant viruses that are excellent for that purpose. Tobacco is a nice plant to use because of TMV (tobacco mosaic virus), but there are others. There are good methods for purification such as Watanabe 1952 or Gooding 1967 http://www.ncbi.nlm.nih.gov/pubmed/6075009
Pingback: TWiV 47: Vertical vaccine farm virology
Pingback: Do women need the same amount of influenza vaccine as men?
Plant derived virus particles are definitely practical. There are a number of plant viruses that are excellent for that purpose. Tobacco is a nice plant to use because of TMV (tobacco mosaic virus), but there are others. There are good methods for purification such as Watanabe 1952 or Gooding 1967 http://www.ncbi.nlm.nih.gov/pubmed/6075009
Early vaccine studies have been done. (Ex: http://www.nature.com/nbt/journal/v13/n1/abs/nb… )
Try talking to Bryce Falk at UCD. He's very knowledgable about TMV and other viruses for protein expression. bwfalk@ucdavis.edu
Plant derived virus particles are definitely practical. There are a number of plant viruses that are excellent for that purpose. Tobacco is a nice plant to use because of TMV (tobacco mosaic virus), but there are others. There are good methods for purification such as Watanabe 1952 or Gooding 1967 http://www.ncbi.nlm.nih.gov/pubmed/6075009
Early vaccine studies have been done. (Ex: http://www.nature.com/nbt/journal/v13/n1/abs/nb… )
Try talking to Bryce Falk at UCD. He's very knowledgable about TMV and other viruses for protein expression. bwfalk@ucdavis.edu